
Kevin P. Kerns
Examiner (ID: 13465)
| Most Active Art Unit | 1735 |
| Art Unit(s) | 1793, 1735, 1725, 1722 |
| Total Applications | 2451 |
| Issued Applications | 1775 |
| Pending Applications | 160 |
| Abandoned Applications | 539 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16569096
[patent_doc_number] => 20210008102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => REGENERATIVE CO2 TREATMENT APPARATUS AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/924873
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16924873
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/924873 | Regenerative CO | Jul 8, 2020 | Issued |
Array
(
[id] => 17341992
[patent_doc_number] => 20220008323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => Skin Moisturizing Formulation
[patent_app_type] => utility
[patent_app_number] => 16/922234
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922234 | Skin moisturizing formulation | Jul 6, 2020 | Issued |
Array
(
[id] => 17805655
[patent_doc_number] => 20220257490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING POLYMER IV
[patent_app_type] => utility
[patent_app_number] => 17/628134
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628134 | METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING POLYMER IV | Jul 5, 2020 | Pending |
Array
(
[id] => 17312685
[patent_doc_number] => 20210401733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SKIN CREME
[patent_app_type] => utility
[patent_app_number] => 16/917023
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16917023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/917023 | SKIN CREME | Jun 29, 2020 | Abandoned |
Array
(
[id] => 17312689
[patent_doc_number] => 20210401737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PREBIOTIC AND PROBIOTIC COOKIE PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/913613
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913613 | Prebiotic and probiotic cookie preparation | Jun 25, 2020 | Issued |
Array
(
[id] => 16798994
[patent_doc_number] => 10993909
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-05-04
[patent_title] => Method and composition for treating upper respiratory tract inflammatory and infectious diseases
[patent_app_type] => utility
[patent_app_number] => 16/906043
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5689
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906043 | Method and composition for treating upper respiratory tract inflammatory and infectious diseases | Jun 18, 2020 | Issued |
Array
(
[id] => 16806054
[patent_doc_number] => 20210128607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/903910
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903910 | POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF | Jun 16, 2020 | Abandoned |
Array
(
[id] => 16806035
[patent_doc_number] => 20210128588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID
[patent_app_type] => utility
[patent_app_number] => 16/903730
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903730 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | Jun 16, 2020 | Abandoned |
Array
(
[id] => 16511482
[patent_doc_number] => 20200390739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => HEMP-BASED NUTRACEUTICAL
[patent_app_type] => utility
[patent_app_number] => 16/902673
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902673 | HEMP-BASED NUTRACEUTICAL | Jun 15, 2020 | Abandoned |
Array
(
[id] => 16939869
[patent_doc_number] => 11052084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
[patent_app_type] => utility
[patent_app_number] => 16/903133
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7884
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903133 | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Jun 15, 2020 | Issued |
Array
(
[id] => 17952359
[patent_doc_number] => 11478431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Ingestible medical delivery devices
[patent_app_type] => utility
[patent_app_number] => 16/902877
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9892
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902877 | Ingestible medical delivery devices | Jun 15, 2020 | Issued |
Array
(
[id] => 16710291
[patent_doc_number] => 20210077438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => COMPOSITIONS AND METHODS FOR REMEDIATING CHEMICAL WARFARE AGENT EXPOSURE AND SURFACE DECONTAMINATION
[patent_app_type] => utility
[patent_app_number] => 16/900816
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900816 | COMPOSITIONS AND METHODS FOR REMEDIATING CHEMICAL WARFARE AGENT EXPOSURE AND SURFACE DECONTAMINATION | Jun 11, 2020 | Pending |
Array
(
[id] => 16341550
[patent_doc_number] => 20200306200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/880639
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880639 | METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER | May 20, 2020 | Abandoned |
Array
(
[id] => 19119803
[patent_doc_number] => 11963761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Mediation of in vivo analyte signal degradation
[patent_app_type] => utility
[patent_app_number] => 16/875424
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5958
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875424 | Mediation of in vivo analyte signal degradation | May 14, 2020 | Issued |
Array
(
[id] => 17783513
[patent_doc_number] => 11406615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Misoprostol dispersible tablet
[patent_app_type] => utility
[patent_app_number] => 16/870556
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6114
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870556 | Misoprostol dispersible tablet | May 7, 2020 | Issued |
Array
(
[id] => 17936980
[patent_doc_number] => 11471412
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-18
[patent_title] => Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration
[patent_app_type] => utility
[patent_app_number] => 16/870446
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14409
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870446 | Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration | May 7, 2020 | Issued |
Array
(
[id] => 17420102
[patent_doc_number] => 11253531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Lipid supplements for reducing nerve action potentials
[patent_app_type] => utility
[patent_app_number] => 16/870868
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 32
[patent_no_of_words] => 25668
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870868 | Lipid supplements for reducing nerve action potentials | May 7, 2020 | Issued |
Array
(
[id] => 19290462
[patent_doc_number] => 12029801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Sunscreen multilayer particle
[patent_app_type] => utility
[patent_app_number] => 17/609531
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5535
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609531 | Sunscreen multilayer particle | May 6, 2020 | Issued |
Array
(
[id] => 17094604
[patent_doc_number] => 20210282395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => TOPICAL ANTISEPTIC SKIN SANITIZING NITROGEN SPRAY
[patent_app_type] => utility
[patent_app_number] => 16/869289
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869289 | TOPICAL ANTISEPTIC SKIN SANITIZING NITROGEN SPRAY | May 6, 2020 | Abandoned |
Array
(
[id] => 17586466
[patent_doc_number] => 11324707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Abuse-deterrent dosage forms containing esketamine
[patent_app_type] => utility
[patent_app_number] => 16/869309
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 27408
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869309
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869309 | Abuse-deterrent dosage forms containing esketamine | May 6, 2020 | Issued |